Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Cabozantinib and Temozolomide in Patients With Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04200443
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:42.335586+00:00
Published At
2026-01-05T00:00:00+00:00
Record Updated At
2026-01-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Leiomyosarcoma", "Metastatic Soft Tissue Sarcoma", "Stage III Uterine Corpus Leiomyosarcoma AJCC v8", "Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8", "Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8", "Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8", "Stage IV Uterine Corpus Leiomyosarcoma AJCC v8", "Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8", "Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8", "Unresectable Leiomyosarcoma", "Unresectable Soft Tissue Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-05"
protocolSection.identificationModule.nctId
"NCT04200443"
protocolSection.identificationModule.officialTitle
"A Phase II Study of Cabozantinib and Temozolomide in Patients With Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Metastatic Leiomyosarcoma (protocolSection.conditionsModule.conditions)
  • Metastatic Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage III Uterine Corpus Leiomyosarcoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Leiomyosarcoma (protocolSection.conditionsModule.conditions)
  • Unresectable Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.